EVTC vs TECH · P/E 18, rev $845.5M vs P/E 65, rev $1.22B
Evertec Inc (EVTC) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Evertec Inc (EVTC) is a software - infrastructure company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported EVTC revenue for 2024-12-31 was $845.5M. Net income was $114.8M. Revenue was up 21.7% from 2023-12-31 to 2024-12-31. EVTC currently screens at market cap $2.34B and trailing P/E 18.2.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
EVTC currently screens at market cap $2.34B and trailing P/E 18.2. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the EVTC and TECH stock pages for the full models.
Not investment advice.